Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:HIMS News 9 January 2026 - 6 February 2026

Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Hims & Hers Health shares fell 3.8% to $23.48 in premarket trading Friday after FDA Commissioner Marty Makary warned of a crackdown on “illegal copycat drugs.” The drop followed Hims’ launch of a $49 compounded version of Novo Nordisk’s Wegovy pill. Novo Nordisk said it would pursue legal and regulatory action, calling Hims’ move “illegal mass compounding.” Investors are watching for FDA enforcement and lawsuits ahead of Hims’ Feb. 23 report.
6 February 2026
····
Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

Hims & Hers Health shares surged to $29.44 before falling back to $24.41 after announcing $49 compounded semaglutide pills. Novo Nordisk said it will sue, calling the move illegal mass compounding. The FDA previously warned Hims about misleading claims on compounded semaglutide. Novo’s branded Wegovy pill will cost $199 per month.
5 February 2026
···
Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

Hims & Hers shares fell 2.2% to $31.00 in premarket trading Monday after a 6.4% drop Friday. The decline followed Amazon Pharmacy’s move to offer Novo Nordisk’s Wegovy weight-loss pill nationwide, intensifying competition in the online obesity drug market. Investors are watching Hims’ upcoming earnings for signs of pressure on its GLP-1 business and marketing costs.
12 January 2026
·
Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears

Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears

Hims & Hers Health shares dropped 6.4% to $31.69 Friday, extending a two-day slide to 11% after Amazon Pharmacy entered the Wegovy weight-loss pill market. BofA cut its price target and kept an Underperform rating, citing high 2026 estimates. The stock closed below key moving averages and neared oversold levels. The FDA previously warned the company over marketing claims for compounded weight-loss drugs.
10 January 2026
··
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers shares dropped 5.3% to $32.06 after Amazon Pharmacy began offering Novo Nordisk’s Wegovy weight-loss pill. Bank of America cut its price target on Hims, citing margin and spending risks for 2026. The stock fell from an intraday high of $34.35. Investors are watching for signs of pricing pressure and updated forecasts ahead of Hims’ next earnings report.
9 January 2026
··

Stock Market Today

OmniVision Class A stock: Hong Kong greenshoe adds shares as stabilisation ends — what to watch next week

OmniVision Class A stock: Hong Kong greenshoe adds shares as stabilisation ends — what to watch next week

8 February 2026
SHANGHAI, February 8, 2026, 10:29 (GMT+8) — Market closed. OmniVision Integrated Circuits Group, Inc. said underwriters partially exercised the over-allotment option in its Hong Kong share sale, issuing 4.94 million H shares at HK$104.80 apiece, according to a Shanghai filing dated Feb. 7. The company said the extra shares will start trading in Hong Kong on Feb. 11 and will bring in HK$511.2 million in additional net proceeds, while the stabilisation period ended on Feb. 6. The filing also detailed stabilisation actions including an over-allocation of 6.87 million H shares, market purchases of 1.93 million H shares at HK$103.00 to
Hua Hong Semiconductor Class A stock price: two dates traders can’t ignore after Friday’s drop

Hua Hong Semiconductor Class A stock price: two dates traders can’t ignore after Friday’s drop

8 February 2026
Hua Hong Semiconductor’s Shanghai-listed shares fell 0.6% to 130.26 yuan Friday, down 16% for the week. Shareholders will vote Feb. 10 on an acquisition and share issuance plan, with a board meeting set for Feb. 12 to review unaudited quarterly results. The company aims to buy nearly all of Shanghai Huali Microelectronics for 8.27 billion yuan, funded by new shares and a private placement.
First Solar stock price slides into next week as Tesla ramps solar hiring; earnings due Feb. 24

First Solar stock price slides into next week as Tesla ramps solar hiring; earnings due Feb. 24

8 February 2026
First Solar shares fell 6.7% to $218.73 Friday, trading over double their 50-day average volume as the broader market rallied. Tesla announced hiring tied to Elon Musk’s 100-gigawatt U.S. solar manufacturing goal. First Solar will report Q4 and full-year 2025 results and 2026 guidance on Feb. 24. Policy changes and competitive moves have heightened volatility in the U.S. solar sector.
GlobalFoundries stock jumps nearly 5% ahead of earnings — what could move GFS next week

GlobalFoundries stock jumps nearly 5% ahead of earnings — what could move GFS next week

8 February 2026
GlobalFoundries shares rose 4.7% to $42.91 Friday as chip stocks rebounded, tracking a surge in the PHLX semiconductor index and renewed bets on AI-driven demand. The company reports earnings Feb. 11, with analysts watching for updates on pricing and wafer shipment volumes. The Semiconductor Industry Association forecast global chip sales could hit $1 trillion in 2026.
Go toTop